[1]熊磊 甘卫东 樊祥山.微血管密度与肾细胞癌预后关系的研究进展[J].中华腔镜泌尿外科杂志(电子版),2016,10(04):284-288.[doi:10.3877/cma.j.issn.1674-3253.2016.04.017 ]
点击复制

微血管密度与肾细胞癌预后关系的研究进展()
分享到:

中华腔镜泌尿外科杂志(电子版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
10
期数:
2016年04期
页码:
284-288
栏目:
综述
出版日期:
2016-08-31

文章信息/Info

作者:
熊磊 1甘卫东 1樊祥山 2
210008南京,南京大学医学院附属鼓楼医院泌尿外科 1,病理科 2
关键词:
肾细胞肿瘤微血管密度预后
DOI:
10.3877/cma.j.issn.1674-3253.2016.04.017

参考文献/References:

[1] Rini B, Campbell SC, Escudier B. Renal cell carcinoma[J]. Lancet, 2009, 373(9669): 1119-1132.
[2] Fukata S, Inoue K, Kamada M, et al. Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma[J]. Cancer, 2005, 103(5): 931-942.
[3] Marech I, Gadaleta CD, Ranieri G. Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma[J]. Int J Mol Sci, 2014, 15(7): 13060-13076.
[4] Sun M, Shariat SF, Cheng C, et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review [J]. Eur Urol, 2011, 60(4): 644-661.
[5] Rioux-Leclercq N, Epstein JI, Bansard JY, et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma [J]. Hum Pathol, 2001, 32(11): 1209-1215.
[6] Folkman J. What is the evidence that tumors are angiogenesis dependent?[J]. J Natl Cancer Inst, 1990, 82(1): 4-6.
[7] Molema G, De Leij L, Meijer DF. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy[J]. Pharm Res, 1997, 14(1): 2-10.
[8] Yoshida S, Amano H, Hayashi I, et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo[J]. Lab Invest, 2003, 83(10): 1385-1394.
[9] Obermair A, Kurz C, Czerwenka K, et al. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival[J]. Int J Cancer, 1995, 62(2): 126-131.
[10] Brawer MK. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma [J]. Cancer, 1996, 78(2): 345-349.
[11] Jaeger TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer [J]. J Urol, 1995, 154(1): 69-71.
[12] Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading [J]. J Natl Cancer Inst, 1972, 48(2): 347-356.
[13] Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma [J].N Engl J Med,1991,324(1):1-8.
[14] Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and Independent prognostic indicator in early-stage breast carcinoma[J]. J Natl Cancer Inst, 1992, 84(24): 1875-1887.
[15] Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma [J]. Am J Pathol, 1993, 143(2): 401-409.
[16] Imao T, Egawa M, Takashima H, et al. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma[J]. Int J Urol, 2004, 11(11): 948-953.
[17] Maclennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of prognostic significance [J]. Urology, 1995, 46 (1): 27-30.
[18] Kirkali Z, Yorukoglu K, Ozkara E, et al. Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma[J]. Int J Urol, 2001, 8(12): 697-703.
[19] Schraml P, Struckmann K, Hatz F, et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma [J]. J Pathol, 2002, 196(2): 186-193.
[20] Sandlund J, Hedberg Y, Bergh A, et al. Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma[J]. Tumour Biol, 2007, 28(3): 158-164.
[21] Sharma SG, Aggarwal N, Gupta SD, et al. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors [J]. Int Urol Nephrol, 2011, 43 (1): 125-129.
[22] Yoshino S, Kato M, Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma[J]. Int J Urol, 1995, 2(3): 156-160.
[23] Nativ O, Sabo E, Reiss A, et al. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma [J]. Urology, 1998, 51(5): 693-696.
[24] Zhang X, Yamashita M, Uetsuki H, et al. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases [J]. Int J Urol, 2002, 9(9): 509-514.
[25] Ren J, Liu H, Yan L, et al. Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances [J]. World J Surg Oncol, 2011, 9: 158.
[26] Sato M, Nakai Y, Nakata W, et al. Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma[J]. Int J Urol, 2014, 21(2): 130-134.
[27] Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma[J]. Br J Urol, 1997, 80(3): 401-404.
[28] Sabo E, Boltenko A, Sova Y, et al. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma[J]. Clin Cancer Res, 2001, 7(3): 533-537.
[29] Sandlund J, Hedberg Y, Bergh A, et al. Endoglin (CD105) expression in human renal cell carcinoma [J]. BJU Int, 2006, 97 (4): 706-710.
[30] Mertz KD, Demichelis F, Kim R, et al. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer [J]. Hum Pathol, 2007, 38(10): 1454-1462.
[31] Yildiz E, Ayan S, Goze F, et al. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma[J]. BJU Int, 2008, 101(6): 758-764.
[32] Qi LF, Sun D, Zheng JH, et al. Detection and clinical significance of platelet derived growth factor-BB and microvessel density in clear cell renal cell carcinoma [J]. Zhonghua Zhong Liu Za Zhi, 2013, 35(9): 672-677.
[33] Zhang B, Ji H, Yan D, et al. Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis[J]. Tumour Biol, 2014, 35(3): 2769-2776.
[34] Qian CN, Huang D, Wondergem B, et al. Complexity of tumor vasculature in clear cell renal cell carcinoma[J]. Cancer, 2009, 115 (10 Suppl): 2282-2289.
[35] Lakovlev VV, Gabril M, Dubinski W, et al. Microvascular density as an Independent predictor of clinical outcome in renal cell carcinoma:an automated image analysis study [J]. Lab Invest, 2012, 92(1): 46-56.
[36]周志平,施鑫. CT灌注成像在肿瘤血管生成中的应用 [J].临床肿瘤学杂志, 2009, 14(12): 1140-1143.

相似文献/References:

[1]晁流,刘宁,甘卫东,等.保留肾单位术与根治性肾切除术对肾功能影响的比较[J].中华腔镜泌尿外科杂志(电子版),2017,11(06):393.[doi:10.3877/cma.j.issn.1674-3253.2017.06.009 ]
 Chao Liu,Liu Ning,Gan Weidong,et al.Comparison of the postoperative renal function between nephron-sparing surgery and radical nephrectomy[J].,2017,11(04):393.[doi:10.3877/cma.j.issn.1674-3253.2017.06.009 ]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金面上项目( 81572512);江苏省自然科学基金面上项目( BK20131281)
通讯作者:甘卫东,Email:gwd@nju.edu.cn
本文编辑:阮星星 李文标) 熊磊,甘卫东,樊祥山,等.微血管密度与肾细胞癌预后关系的研究进展[J/CD].中华腔镜泌尿外科杂志:电子版, 2016, 10 (4
更新日期/Last Update: 2016-08-30